Riskpilot← Back to searchSign inGet full accessWSG Uroxen AB
ABActiveOrg 5590950886Värmlands-Säby Gård 1Rental and operating of own or leased real estate · NACE 6820Est. 20160 employees
Revenue 2024
SEK 3,3M
+4% vs 2023
EBITDA margin
62.4%
-4% vs 2023
Equity ratio
9.5%
Financial strength
Net profit 2024
SEK 829K
+1627% vs 2023
| Revenue | SEK 3,3M | +4% |
| EBITDA | SEK 2M | -4% |
| Net profit | SEK 829K | +1627% |
| Total assets | SEK 16,5M | +4% |
| Equity | SEK 1,6M | +113% |
| Employees | 0 | — |
Legal name
WSG Uroxen AB
Org number
5590950886
Legal form
Aktiebolag
NACE code
6820 · Rental and operating of own or leased real estate
Founded
30 december 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska äga och förvalta fastigheter samt bedriva därmed förenlig verksamhet.
Address
Värmlands-Säby Gård 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 737 | 2 757 | 2 826 | 3 153 | 3 279 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 585 | 1 964 | 1 917 | 2 125 | 2 045 |
| Depreciation & amort. | −457 | −457 | −457 | −457 | −457 |
| EBIT | 1 128 | 1 507 | 1 460 | 1 668 | 1 588 |
| Net financials | −322 | −326 | −338 | −343 | −556 |
| Profit before tax | 476 | 181 | 22 | 69 | 1 055 |
| Tax | −0 | −38 | −6 | −21 | −226 |
| Net profit | 476 | 143 | 16 | 48 | 829 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 17 806 | 17 174 | 16 630 | 15 859 | 16 530 |
| Equity | 529 | 672 | 688 | 736 | 1 565 |
| Long-term debt | 15 043 | 14 440 | 13 560 | 12 880 | 12 600 |
| Short-term debt | 1 285 | 1 114 | 1 434 | 1 538 | 1 682 |
| Total debt | 16 328 | 15 554 | 14 994 | 14 418 | 14 282 |
EBITDA margin
62.4%
This company
15.8%
Market median
+295% vs market
20202024
Equity ratio
9.5%
This company
38.2%
Market median
-75% vs market
20202024
Return on equity
53.0%
This company
18.4%
Market median
+188% vs market
20202024
Net profit margin
25.3%
This company
8.1%
Market median
+212% vs market
20202024
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
20202024
Debt / equity
9.56×
This company
0.62×
Market median
-1442% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Former (4) | ||
| Deputy Board Member | 2021 – 2022 | |
| Chairman | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
WSG-Intressenter Aktiebolag
WSG Uroxen AB Board members of WSG Uroxen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Ingegerd Marie-Louise Ångell Andersson | Deputy Board Member | 0 companies |
| Jochum Gabriel Beck-Friis | Chairman | 0 companies |
| Jockum Nils Gustaf Beck-Friis | Board of Directors | 0 companies |
| Anders Börje Andersson | Chairman | 0 companies |
| Jaspal Singh Åberg | Board of Directors | 0 companies |
| Alicja Åberg | Deputy Board Member | 0 companies |
| Carl Herman Gabriel Beck-Friis | Board of Directors | 0 companies |